Benutzerspezifische Werkzeuge

Development and validation of a new cell isolation technology for therapeutic application in immunoncology (CC Top)

European Fund for Regional Development (EFRE) and European Social Fund (ESF) via Sächsische Aufbaubank (SAB)

Subtopic: Validation of new antibody fragments and validation of isolated NK cells for the production and purification of CAR-NK cell products in suitable tumor models

In this project, a novel and gentle purification technology for NK cells from patient blood will be developed on a clinically relevant scale. The NK cells obtained in this way will be subjected to various quality and functional analyses. In addition, the isolated NK cells will be tested for their suitability for the generation of CAR NK cells. The CAR-modified NK cells will be isolated using the new technology in order to produce a highly pure CAR-NK cell product for therapeutic use.

>> German version